ETC
Exchange Traded Concepts’s Fate Therapeutics FATE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-131,830
| Closed | -$104K | – | 1420 |
|
|
2025
Q1 | $104K | Buy |
131,830
+89,541
| +212% | +$70.7K | ﹤0.01% | 1144 |
|
|
2024
Q4 | $69.8K | Hold |
42,289
| – | – | ﹤0.01% | 1190 |
|
|
2024
Q3 | $148K | Buy |
42,289
+12,230
| +41% | +$42.8K | ﹤0.01% | 1068 |
|
|
2024
Q2 | $98.6K | Sell |
30,059
-9,351
| -24% | -$30.7K | ﹤0.01% | 939 |
|
|
2024
Q1 | $289K | Sell |
39,410
-24,315
| -38% | -$178K | 0.01% | 811 |
|
|
2023
Q4 | $238K | Buy |
63,725
+16,159
| +34% | +$60.4K | 0.01% | 773 |
|
|
2023
Q3 | $101K | Buy |
47,566
+21,955
| +86% | +$46.5K | ﹤0.01% | 891 |
|
|
2023
Q2 | $122K | Sell |
25,611
-196,990
| -88% | -$938K | ﹤0.01% | 905 |
|
|
2023
Q1 | $1.27M | Buy |
222,601
+181,304
| +439% | +$1.03M | 0.03% | 289 |
|
|
2022
Q4 | $417K | Buy |
41,297
+10,186
| +33% | +$103K | 0.01% | 556 |
|
|
2022
Q3 | $697K | Sell |
31,111
-5,739
| -16% | -$129K | 0.02% | 322 |
|
|
2022
Q2 | $913K | Buy |
36,850
+2,586
| +8% | +$64.1K | 0.03% | 306 |
|
|
2022
Q1 | $1.33M | Buy |
34,264
+4,465
| +15% | +$173K | 0.03% | 283 |
|
|
2021
Q4 | $1.74M | Buy |
29,799
+5,201
| +21% | +$304K | 0.03% | 256 |
|
|
2021
Q3 | $1.46M | Buy |
+24,598
| New | +$1.46M | 0.04% | 266 |
|
|
2021
Q2 | – | Sell |
-2,039
| Closed | -$168K | – | 1147 |
|
|
2021
Q1 | $168K | Sell |
2,039
-9,103
| -82% | -$750K | 0.01% | 676 |
|
|
2020
Q4 | $1.01M | Sell |
11,142
-6,818
| -38% | -$620K | 0.05% | 225 |
|
|
2020
Q3 | $718K | Buy |
+17,960
| New | +$718K | 0.04% | 211 |
|